This inventor holds 1 USPTO granted patent and 11 published patent applications. Top assignee: Molecular Partners Ag. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Christian Reichen: Innovator in Multi-Specific T-Cell Engagers
Introduction
Christian Reichen is a notable inventor based in Schlieren, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of multi-specific proteins for therapeutic applications.
Latest Patents
Christian Reichen holds a patent for "DARPin based multi-specific t-cell engagers." This invention relates to recombinant multi-specific proteins that comprise binding agents with specificity for various targets, including CD3, CD33, CD123, and CD70. The patent also covers nucleic acids encoding these multi-specific proteins, pharmaceutical compositions containing them, and their use in treating or diagnosing diseases such as acute myeloid leukaemia (AML) in mammals, including humans.
Career Highlights
Christian Reichen is associated with Molecular Partners AG, a company that focuses on innovative biopharmaceuticals. His work has been instrumental in advancing therapeutic strategies that leverage the immune system to combat cancer.
Collaborations
Christian collaborates with talented professionals in his field, including Nina Reschke and Sebastian Grimm. Their combined expertise contributes to the innovative research and development efforts at Molecular Partners AG.
Conclusion
Christian Reichen's work in the development of multi-specific t-cell engagers represents a significant advancement in cancer treatment. His contributions to biotechnology continue to pave the way for new therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile